EP1858535A4 - Compositions comprising actinidia and methods of use thereof - Google Patents
Compositions comprising actinidia and methods of use thereofInfo
- Publication number
- EP1858535A4 EP1858535A4 EP06735914A EP06735914A EP1858535A4 EP 1858535 A4 EP1858535 A4 EP 1858535A4 EP 06735914 A EP06735914 A EP 06735914A EP 06735914 A EP06735914 A EP 06735914A EP 1858535 A4 EP1858535 A4 EP 1858535A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- actinidia
- compositions
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 241000219068 Actinidia Species 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Communicable Diseases (AREA)
- Medical Informatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65683905P | 2005-02-25 | 2005-02-25 | |
US65683805P | 2005-02-25 | 2005-02-25 | |
PCT/US2006/006437 WO2006093793A2 (en) | 2005-02-25 | 2006-02-24 | Compositions comprising actinidia and methods of use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1858535A2 EP1858535A2 (en) | 2007-11-28 |
EP1858535A4 true EP1858535A4 (en) | 2012-05-02 |
Family
ID=36941647
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP06735914A Withdrawn EP1858535A4 (en) | 2005-02-25 | 2006-02-24 | Compositions comprising actinidia and methods of use thereof |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1858535A4 (en) |
JP (1) | JP2008531584A (en) |
AU (1) | AU2006218875B2 (en) |
BR (1) | BRPI0608042A2 (en) |
MX (1) | MX2007010408A (en) |
RU (1) | RU2423139C2 (en) |
TW (1) | TWI385007B (en) |
WO (1) | WO2006093793A2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080175888A1 (en) * | 2005-02-25 | 2008-07-24 | Julie Lindemann | Combination Therapy Comprising Actinidia and Steroids and Uses Thereof |
DE102006055210A1 (en) * | 2006-11-21 | 2008-05-29 | Ionescu, John G., Dr. | Dietary food with increased free radical binding effect |
KR101141182B1 (en) | 2009-05-12 | 2012-05-02 | 재단법인 제주테크노파크 | Composition for Anti-inflammation |
TWI583312B (en) | 2009-08-12 | 2017-05-21 | 梅拉洛伊卡公司 | Dietary supplements and methods for treating pain and inflammation |
JP4750202B2 (en) * | 2009-10-16 | 2011-08-17 | 株式会社 藍匠 | Method for producing health supplements using Sarnashi |
ES2634034T5 (en) * | 2009-12-29 | 2020-09-18 | Nestle Sa | Nutritional compositions with fruit flakes containing docosahexenoic acid |
JP5688233B2 (en) * | 2010-04-23 | 2015-03-25 | ポーラ化成工業株式会社 | TARC production inhibitor |
JP6179840B2 (en) * | 2011-11-30 | 2017-08-16 | 国立大学法人 岡山大学 | Highly polar organic solvent extract from Sarnashi and its utilization |
JP6242669B2 (en) * | 2013-11-27 | 2017-12-06 | 日本メナード化粧品株式会社 | Hyaluronic acid production promoter containing a sarnashi extract |
CN105410588B (en) * | 2015-11-06 | 2018-05-08 | 四川兴食尚科技有限公司 | A kind of Kiwi berry effervescent tablet and its preparation process |
CN112166325A (en) * | 2018-05-22 | 2021-01-01 | N·V·努特里奇亚 | Biomarkers for improving nutrition of at-risk infants |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040022914A1 (en) * | 2002-06-07 | 2004-02-05 | Allen Ann De Wees | Novel sweetener compositions and methods of use |
WO2004017982A1 (en) * | 2002-08-23 | 2004-03-04 | Pangenomics Co., Ltd | Composition comprising the extract of actinidia arguta and related species for the prevention and treatment of allergic disease and non-allergic inflammatory disease |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5242814A (en) * | 1989-10-10 | 1993-09-07 | Eli Lilly And Company | Polyether antibiotic |
DE19758090B4 (en) * | 1997-12-18 | 2008-10-16 | Maria Endres | Composition and its use in cosmetics and medicine |
DE60119699T2 (en) * | 2001-03-29 | 2007-04-26 | Council Of Scientific And Industrial Research | PROCESS FOR PRODUCING FRUIT WINE FROM BERRIES OF HIMALAYA |
US6811796B2 (en) * | 2002-04-22 | 2004-11-02 | Matsuura Yakugyo Co., Ltd. | Preventive or therapeutic agent for pollen allergy, allergic rhinitis, atopic dermatitis, asthma or urticaria, or health food for prevention or improvement or reduction of symptoms thereof |
-
2006
- 2006-02-24 AU AU2006218875A patent/AU2006218875B2/en not_active Ceased
- 2006-02-24 RU RU2007135365/14A patent/RU2423139C2/en not_active IP Right Cessation
- 2006-02-24 EP EP06735914A patent/EP1858535A4/en not_active Withdrawn
- 2006-02-24 BR BRPI0608042-1A patent/BRPI0608042A2/en not_active IP Right Cessation
- 2006-02-24 TW TW095106341A patent/TWI385007B/en not_active IP Right Cessation
- 2006-02-24 JP JP2007557161A patent/JP2008531584A/en active Pending
- 2006-02-24 MX MX2007010408A patent/MX2007010408A/en active IP Right Grant
- 2006-02-24 WO PCT/US2006/006437 patent/WO2006093793A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040022914A1 (en) * | 2002-06-07 | 2004-02-05 | Allen Ann De Wees | Novel sweetener compositions and methods of use |
WO2004017982A1 (en) * | 2002-08-23 | 2004-03-04 | Pangenomics Co., Ltd | Composition comprising the extract of actinidia arguta and related species for the prevention and treatment of allergic disease and non-allergic inflammatory disease |
Non-Patent Citations (1)
Title |
---|
KIM YOO KYUNG ET AL: "Anti-inflammation activity of Actinidia polygama", ARCHIVES OF PHARMACAL RESEARCH, NATL. FISHERIES UNIVERSITY, PUSAN, KR, vol. 26, no. 12, 1 December 2003 (2003-12-01), pages 1061 - 1066, XP002528453, ISSN: 0253-6269, DOI: 10.1007/BF02994759 * |
Also Published As
Publication number | Publication date |
---|---|
TW200716226A (en) | 2007-05-01 |
AU2006218875B2 (en) | 2012-08-09 |
WO2006093793A8 (en) | 2008-03-27 |
WO2006093793A2 (en) | 2006-09-08 |
MX2007010408A (en) | 2008-03-25 |
RU2007135365A (en) | 2009-03-27 |
JP2008531584A (en) | 2008-08-14 |
EP1858535A2 (en) | 2007-11-28 |
BRPI0608042A2 (en) | 2009-11-03 |
WO2006093793A3 (en) | 2006-12-07 |
AU2006218875A1 (en) | 2006-09-08 |
TWI385007B (en) | 2013-02-11 |
RU2423139C2 (en) | 2011-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2024476A4 (en) | Compositions comprising low-dp polymerized surfactants and methods of use thereof | |
EP1858535A4 (en) | Compositions comprising actinidia and methods of use thereof | |
EP1973986A4 (en) | Bioactive complex compositions and methods of use thereof | |
PL2335782T3 (en) | Use of compositions comprising HFCO-1233zd | |
EP1851335A4 (en) | Compositions and methods of use of standardized mixtures | |
EP1883389A4 (en) | Low-irritation compositions and methods of making the same | |
PL1888081T3 (en) | Compositions containing pufa and methods of use thereof | |
HK1213814A1 (en) | Diclofenac formulations and methods of use | |
IL190885A0 (en) | Immunogenic compositions and methods of use | |
EP1895838A4 (en) | Compositions and methods | |
SI3255115T1 (en) | Compositions consisting of hfc-1234yf and hfc-134a | |
EP1735456A4 (en) | Polymeric compositions and related methods of use | |
IL185309A0 (en) | Isoqunoline compounds and methods of use thereof | |
EP1933805A4 (en) | Anti-inflammatory compositions and methods of use | |
EP2021448A4 (en) | Compositions comprising low-dp polymerized surfactants and methods of use thereof | |
HK1109576A1 (en) | Aequorin-containing compositions and methods of using same | |
EP2069452A4 (en) | Onium-containing cmp compositions and methods of use thereof | |
EP1765321A4 (en) | Antimicrobial compositions and methods of use thereof | |
EP2021447A4 (en) | Compositions comprising low-dp polymerized surfactants and methods of use thereof | |
GB0520930D0 (en) | Composition and method of use | |
EP1769007A4 (en) | Polymeric compositions and related methods of use | |
GB0504657D0 (en) | Compositions and methods of treatment | |
EP1906950A4 (en) | Ansamycin formulations and methods of use thereof | |
GB0501348D0 (en) | Compositions and methods | |
IL186277A0 (en) | Dnt-maleate and methods of preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20070924 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: EFFICAS, INC. Owner name: PANGENOMICS CO., LTD. |
|
R17D | Deferred search report published (corrected) |
Effective date: 20080327 |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20120403 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 36/00 20060101AFI20120328BHEP Ipc: A61P 11/06 20060101ALI20120328BHEP Ipc: A61P 37/08 20060101ALI20120328BHEP |
|
17Q | First examination report despatched |
Effective date: 20130411 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20130903 |